PTU™ 50 mg Tablets (propylthiouracil)

There is currently a shortage of propylthiouracil in the Canadian market. Given the medical necessity of this product for patients in Canada, Health Canada has added Phebra’s PTU™ (propylthiouracil) 50 mg tablets to the List of Drugs for Exceptional Importation and Sale, as an interim measure to help mitigate the shortage.

Each PTU™ tablet contains 50 mg of propylthiouracil as the active ingredient. Excipient with known effect: lactose monohydrate. The tablet is gluten free.

PTU™ 50 mg Tablets are white, round, biconvex and uncoated. One side is debossed ‘PRESTAB’ and other side is plain.

Indication:
Propylthiouracil is an antithyroid drug indicated for the total treatment of hyperthyroidism or in the treatment of the thyrotoxic patient prior to surgery or radioactive iodine therapy.

  • Strength: 50 mg tablets
  • Package: 100 tablet amber glass bottle
  • Status: Drugs for Exceptional Importation and Sale
  • Phebra Code: TAB001
  • Pack Size: 12 bottles

Resources: